Practical guidance for procedures related to Brexit for medicinal products for human and veterinary use within the framework of the centralised procedure

Europe – Commission launches a public consultation and a call for evidence for EU...

The Commission has launched a public consultation and a call for evidence on the EU’s legislation on medical devices and in vitro diagnostic medical devices, as...
MHRA Offers Grace Period for Device Manufacturers Dealing With Withdrawn Notified Bodies

UK – Medical Devices Regulatory Reform – Roadmap to implementation – Update

A roadmap outlining the intended timelines for delivering a future regulatory framework for medical devices and an intended policy on international recognition...

Europe – MDCG 2024-16: Manufacturer Information Form on Interruption or Discontinuation of Supply of...

The Medical Device Coordination Group (MDCG) has introduced new guidance under MDCG 2024-16, streamlining how manufacturers report interruptions or discontinuations in the supply of...

USA – Final FDA guidance on PCCP includes clarification on version control

The US Food and Drug Administration (FDA) has finalized a long-anticipated guidance on using predetermined change control plans (PCCPs) in submissions for medical devices...

Europe – MDCG 2024-15 – Guidance on the publication of the clinical investigation reports...

Article 77(5) MDR requires that the sponsor submits to the Member States in which a clinical investigation was conducted a clinical investigation report within...
TEAM-NB : Survey on NBs applications against IVD new regulation

Europe – Medical devices AI questionnaire IG-NB & Team NB

This questionnaire is jointly published by the German Notified Bodies Alliance for Medical Devices (Interessengemeinschaft der Benannten Stellen für Medizinprodukte in Deutschland - IGNB)...

Europe – MDCG 2024-14 – Guidance on the implementation of the Master UDI-DI solution...

The introduction of the Unique Device Identification (UDI) system referred to in Article 27 of Regulation (EU) 2017/745 on medical devices (MDR) aims to...

France – PLFSS 2025: le gouvernement veut actionner la clause de sauvegarde sur les...

Le gouvernement a déposé un amendement (au PLFSS 2025 afin- de modifier le montant Z au-delà duquel la clause de sauvegarde "produits et prestations"...

Europe – Gradual roll out of EUDAMED – Q&As on practical aspects related to...

The amendment of the MDR and of the IVDR through Regulation (EU) 2024/1860 addresses three topics: 1. Regulation (EU) 2024/1860 aims to ensure a high...

USA – FDA finalizes guidance on 510(k) third-party reviews

The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health (CDRH) on Thursday finalized guidance to assist manufacturers in using an...

NOS PROCHAINES FORMATIONS